Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Eli Lilly and Company, 3 years.
Eli Lilly and Company
Director · President, Chair, and CEO
Adobe Inc.
Director
Chief executive roles
Eli Lilly and Company
· President, Chair, and CEO
Dates unknown
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Eli Lilly and Company May 4, 202696.2%
-
Adobe Inc. April 15, 202695.3%
-
Adobe Inc. April 22, 202598.7%
-
Adobe Inc. April 17, 202497.4%
-
Eli Lilly and Company May 1, 202395.9%
-
Adobe Inc. April 20, 202397.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 25, 2026 | Adobe Inc. | Open-market purchase | +10,000 | $194.51 | $1,945,100 |
| Apr 15, 2026 | Adobe Inc. | Option exercise | +900 | — | — |
| Feb 9, 2026 | Eli Lilly and Company | Grant or award | +38,914 | $1,044.67 | $40,651,850 |
| Feb 1, 2026 | Eli Lilly and Company | Option exercise | +31,932 | — | — |
| Feb 1, 2026 | Eli Lilly and Company | Shares withheld for tax | −14,297 | $1,037.15 | $14,827,771 |
| Nov 10, 2025 | Eli Lilly and Company | Gift | −24,750 | — | — |
| Aug 12, 2025 | Eli Lilly and Company | Open-market purchase | +1,632 | $644.77 | $1,052,265 |
| Apr 22, 2025 | Adobe Inc. | Option exercise | +633 | — | — |
| Feb 10, 2025 | Eli Lilly and Company | Grant or award | +55,132 | $868.88 | $47,902,710 |
| Feb 1, 2025 | Eli Lilly and Company | Option exercise | +26,561 | — | — |
| Feb 1, 2025 | Eli Lilly and Company | Shares withheld for tax | −11,903 | $811.08 | $9,654,602 |
| Jan 28, 2025 | Adobe Inc. | Open-market purchase | +2,250 | $443.98 | $998,955 |
| Aug 20, 2024 | Eli Lilly and Company | Gift | −13,727 | — | — |
| Apr 17, 2024 | Adobe Inc. | Option exercise | +836 | — | — |
| Feb 12, 2024 | Eli Lilly and Company | Grant or award | +38,392 | $737.26 | $28,304,886 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.